Our Strategy
Our Strategy
- Our experience and connections with seasoned professionals, clinical investigators, and industries worldwide enables us to make an impact. We can rapidly assemble researchers to coordinate early-stage drug production, non-clinical testing, and regulatory submissions. This process allows us to obtain “confidence building” evidence for continued development of new drugs. At ScintiQuant, we assume responsibility for the entire clinical trial development process and work flexibly with companies to achieve this efficiently. Our goal is to bring a new therapeutic agent to the clinic ethically and expeditiously without compromising our commitment to the highest quality.
- Able to extend a company’s bandwidth and resources into new treatment areas.
- Serve as a sponsor for an early stage exploratory or therapeutic IND with straightforward and simplified contracts. This allows our clients to retain anonymity and control of intellectual property, as well as reduce exposure and liability for our client.
Voluptate Velit
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor.
Cillum Dolore
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor.
